• About
  • Subscribe
  • Advertise
  • Contact
Saturday, December 6, 2025
Newsletter
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
Home

Casting some new light on visual field test

by Staff Writer
January 7, 2019
in News
Reading Time: 4 mins read
A A
Share on FacebookShare on Twitter

In the mid 1960s Friedmann developed a tangent perimeter, which I used as a student. The early version was a manual device; complex to use but popular with optometrists.Automated perimetry originated in the 1980s, with the Humphrey Company commercialising some of the very first units. These devices were large bowls calibrated for light output, and automation took care of the test staircase. In those days, perimetry required some 8 to12 minutes for testing a normal eye, and 15 to 20 minutes when testing an abnormal eye. My experience is that patients find the test both lengthy and onerous.Over the years, bowl size has shrunk and test time shortened with the SITA suite of Bayesian thresholding: SITA standard, SITA fast (30% faster) and now SITA faster (50% faster). Although these developments are speeding up testing to about 4 minutes per eye, the cost of these devices rains high and they require space in clinics, as well as trained operators.What is most surprising is that the current generation of automated perimeters do not include enhancents learned over the past 30 years. In fact, the grids and test approaches (spot size) are the same as those of the past. In this aspect nothing has changed, and we are still using the dated approaches of Goldmann.{{quote-A:R-W:400-Q: What is most surprising is that the current generation of automated perimeters do not include enhancents learned over the past 30 years }}There is now a large body of evidence that shows that the standard (24-2 and 30-2) grids under-sample the macula, the region of highest density of retinal ganglion cells, so in many cases clinicians need to put patients through a second test, the 10-2. What a pain for both the patient and clinician.Carl Zeis Meditec recently addressed macula under-sampling by developing the 24-2C grid. This new grid has an extra 10 points within the central 10 degrees for a total of 22 macula test points. However, this compares poorly to the 68 points of a 10-2 grid over the same area. Given that the 24-2C locations have been optimised for glaucoma, will they cope with the more common causes of central vision loss such as AMD or macula oeda?I believe, as many others also do, that this past knowledge can seed better perimeters, as is the case of our tangent device Melbourne Rapid Field (MRF).As clinicians, both Dr George Kong (who is my business partner, a glaucoma surgeon and IT expert) and I appreciate the expense that perimetric bowls place on a practice. We wanted to create a compact device that would fit into modern rooms yet be portable for vision testing; anywhere, anytime, by anyone.Our approach surveyed modern technology to find the ideal stimulus generator. This yielded goggles, smart-phones and tablets. We chose a tablet because they are portable, compact, ubiquitous and most folks know how to use th. The only other device to share these characteristics is a smart-phone, but its size limits its use for perimetry.We wanted a test for all applications but realising that vision loss varies with disease, we optimised designs to include three forms of acuity that identify refractive/optical changes, retinal or brain losses and four grid patterns specific to: glaucoma, maculopathy, diabetes and neural diseases.The novel implentations in these designs are: a spot size that increases with eccentricity to reduce threshold variability; an expanding test grid to define edges of vision loss and a Bayes threshold predictor with neighbourhood logic to return fast, reliable thresholds (2-3 minutes).We have also designed the test for your high-risk patients to use at home as part of a self-monitoring program. This includes a voice-over set of instructions that guides patients through the test. Their results are transmitted by broadband to secure servers (HIPAA compliant) where the data is stored and analysed. If change is confirmed, the clinician is notified. This allows intervention tailored to each patient’s disease with ongoing charges being less than a glass of beer for each visual field test.In contrast to present commercial devices, the MRF is based on advances made over the past 30 years of vision and perimetry testing. I believe it heralds a new era of comprehensive vision assessment and patient monitoring, using cheap and portable tablet technology. I hope that our work can make a significant contribution to eyecare professions.

Name: Algis J VingrysQualifications: BSc(Optom), PhDWorkplace: The University of MelbournePosition: Professor, Department of Optometry & Vision Sciences; Founding Director GLANCE Optical Pty Ltd.Location: MelbourneYears in the profession: 35

 

Related Posts

Macular disease consumes 12% of age pension payments, MDFA says. Images: dragonstock/stock.adobe.com & Robyn Mackenzie/Shutterstock.com.

Government flags major shift in PHI claiming for intravitreal injections

by Staff Writer
December 5, 2025

Eyecare practitioners are being advised to prepare for potential disruption to patient billing pathways, with the federal government considering changes...

The ASO believes expanding the medications optometrists can prescribe could put Australians at risk. Image: Johnstocker/stock.adobe.com.

‘We are not seeking to become doctors’ – OA responds to ASO concerns on prescribing

by Rob Mitchell
December 4, 2025

Optometry Australia (OA) says optometrists are “not seeking to become doctors” through proposed changes to rules governing the medicines they...

Associate Professor Raymond Wong (left) and Associate Professor Mohit Shivdasani have each received research funding. Image: Retina Australia

Pioneering sight-restoration projects secure Retina Australia funding

by Staff Writer
December 4, 2025

Retina Australia has announced the recipients of its 2026 research grants, funding two projects that aim to advance potential new...

Join our newsletter

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

Insight has been the leading industry publication in Australia for more than 40 years. This longevity is largely due to our ability to consistently deliver accurate and independent news relevant to all ophthalmic professionals and their supporting industry.

Subscribe to our newsletter

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

About Insight

  • About
  • Advertise
  • Subscribe
  • Contact
  • Terms & Conditions
  • Privacy Collection Notice
  • Privacy Policy

Popular Topics

  • Business
  • Feature
  • Research
  • Technology
  • Therapies
  • Classifieds

© 2025 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited

No Results
View All Results
NEWSLETTER
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
  • About Us
  • Advertise with Insight
  • Subscribe
  • Contact Insight

© 2025 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited